Margaret Ann Miller TabsBio Margaret Ann Miller received her Ph.D. in Endocrinology-Reproductive Physiology from the University of Wisconsin-Madison in 1981. Following her degree she was a postdoctoral fellow at the University of Illinois, Champaign-Urbana, in the laboratory of Dr. Benita Katzenellenbogen, where she conducted research on the estrogen receptor. In 1985, Dr. Miller accepted a position at Monsanto Agricultural Company, where she supervised a laboratory supporting the research and clinical studies needed for the approval of recombinant products, including bovine somatotropin. In 1989, Dr. Miller joined the United States Food and Drug Administration (FDA) in the Division of Toxicology, Office of New Animal Drug Evaluation in the Center for Veterinary Medicine (CVM). She held several positions within the CVM, including Deputy Director for Human Food Safety in the Office of New Animal Drug Evaluation. In 1999, Dr. Miller joined FDA's Office of Women's Health as the Manager of Science Programs. In this position she initiated several successful research initiatives aimed at promoting the health of women. She recently completed a two-year detail at the World Health Organization, where she worked on food safety. Dr. Miller is currently the Associate Director of Regulatory Activities in the Washington Office of the National Center for Toxicological Research, where she coordinates activities between the Center and Headquarters.